Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Treatment Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Vaccine
1.2.3 Drugs
1.3 Market by Application
1.3.1 Global mRNA Treatment Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Protein Diseases
1.3.3 Gene Dysfunction Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Treatment Market Perspective (2018-2034)
2.2 mRNA Treatment Growth Trends by Region
2.2.1 Global mRNA Treatment Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 mRNA Treatment Historic Market Size by Region (2018-2023)
2.2.3 mRNA Treatment Forecasted Market Size by Region (2024-2034)
2.3 mRNA Treatment Market Dynamics
2.3.1 mRNA Treatment Industry Trends
2.3.2 mRNA Treatment Market Drivers
2.3.3 mRNA Treatment Market Challenges
2.3.4 mRNA Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Treatment Players by Revenue
3.1.1 Global Top mRNA Treatment Players by Revenue (2018-2023)
3.1.2 Global mRNA Treatment Revenue Market Share by Players (2018-2023)
3.2 Global mRNA Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Treatment Revenue
3.4 Global mRNA Treatment Market Concentration Ratio
3.4.1 Global mRNA Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Treatment Revenue in 2024
3.5 mRNA Treatment Key Players Head office and Area Served
3.6 Key Players mRNA Treatment Product Solution and Service
3.7 Date of Enter into mRNA Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Treatment Breakdown Data by Type
4.1 Global mRNA Treatment Historic Market Size by Type (2018-2023)
4.2 Global mRNA Treatment Forecasted Market Size by Type (2024-2034)
5 mRNA Treatment Breakdown Data by Application
5.1 Global mRNA Treatment Historic Market Size by Application (2018-2023)
5.2 Global mRNA Treatment Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America mRNA Treatment Market Size (2018-2034)
6.2 North America mRNA Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America mRNA Treatment Market Size by Country (2018-2023)
6.4 North America mRNA Treatment Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Treatment Market Size (2018-2034)
7.2 Europe mRNA Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe mRNA Treatment Market Size by Country (2018-2023)
7.4 Europe mRNA Treatment Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Treatment Market Size (2018-2034)
8.2 Asia-Pacific mRNA Treatment Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific mRNA Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific mRNA Treatment Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Treatment Market Size (2018-2034)
9.2 Latin America mRNA Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America mRNA Treatment Market Size by Country (2018-2023)
9.4 Latin America mRNA Treatment Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Treatment Market Size (2018-2034)
10.2 Middle East & Africa mRNA Treatment Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa mRNA Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa mRNA Treatment Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 CureVac
11.1.1 CureVac Company Detail
11.1.2 CureVac Business Overview
11.1.3 CureVac mRNA Treatment Introduction
11.1.4 CureVac Revenue in mRNA Treatment Business (2018-2023)
11.1.5 CureVac Recent Development
11.2 Moderna
11.2.1 Moderna Company Detail
11.2.2 Moderna Business Overview
11.2.3 Moderna mRNA Treatment Introduction
11.2.4 Moderna Revenue in mRNA Treatment Business (2018-2023)
11.2.5 Moderna Recent Development
11.3 BioNTech (Pfizer)
11.3.1 BioNTech (Pfizer) Company Detail
11.3.2 BioNTech (Pfizer) Business Overview
11.3.3 BioNTech (Pfizer) mRNA Treatment Introduction
11.3.4 BioNTech (Pfizer) Revenue in mRNA Treatment Business (2018-2023)
11.3.5 BioNTech (Pfizer) Recent Development
11.4 Sanofi (Translate Bio)
11.4.1 Sanofi (Translate Bio) Company Detail
11.4.2 Sanofi (Translate Bio) Business Overview
11.4.3 Sanofi (Translate Bio) mRNA Treatment Introduction
11.4.4 Sanofi (Translate Bio) Revenue in mRNA Treatment Business (2018-2023)
11.4.5 Sanofi (Translate Bio) Recent Development
11.5 Ethris (AstraZeneca)
11.5.1 Ethris (AstraZeneca) Company Detail
11.5.2 Ethris (AstraZeneca) Business Overview
11.5.3 Ethris (AstraZeneca) mRNA Treatment Introduction
11.5.4 Ethris (AstraZeneca) Revenue in mRNA Treatment Business (2018-2023)
11.5.5 Ethris (AstraZeneca) Recent Development
11.6 Kernal Biologics
11.6.1 Kernal Biologics Company Detail
11.6.2 Kernal Biologics Business Overview
11.6.3 Kernal Biologics mRNA Treatment Introduction
11.6.4 Kernal Biologics Revenue in mRNA Treatment Business (2018-2023)
11.6.5 Kernal Biologics Recent Development
11.7 RaNA Therapeutics
11.7.1 RaNA Therapeutics Company Detail
11.7.2 RaNA Therapeutics Business Overview
11.7.3 RaNA Therapeutics mRNA Treatment Introduction
11.7.4 RaNA Therapeutics Revenue in mRNA Treatment Business (2018-2023)
11.7.5 RaNA Therapeutics Recent Development
11.8 Silence Therapeutics
11.8.1 Silence Therapeutics Company Detail
11.8.2 Silence Therapeutics Business Overview
11.8.3 Silence Therapeutics mRNA Treatment Introduction
11.8.4 Silence Therapeutics Revenue in mRNA Treatment Business (2018-2023)
11.8.5 Silence Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global mRNA Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Vaccine
Table 3. Key Players of Drugs
Table 4. Global mRNA Treatment Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 5. Global mRNA Treatment Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global mRNA Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global mRNA Treatment Market Share by Region (2018-2023)
Table 8. Global mRNA Treatment Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 9. Global mRNA Treatment Market Share by Region (2024-2034)
Table 10. mRNA Treatment Market Trends
Table 11. mRNA Treatment Market Drivers
Table 12. mRNA Treatment Market Challenges
Table 13. mRNA Treatment Market Restraints
Table 14. Global mRNA Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global mRNA Treatment Market Share by Players (2018-2023)
Table 16. Global Top mRNA Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Treatment as of 2024)
Table 17. Ranking of Global Top mRNA Treatment Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by mRNA Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players mRNA Treatment Product Solution and Service
Table 21. Date of Enter into mRNA Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global mRNA Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global mRNA Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global mRNA Treatment Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 26. Global mRNA Treatment Revenue Market Share by Type (2024-2034)
Table 27. Global mRNA Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global mRNA Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global mRNA Treatment Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 30. Global mRNA Treatment Revenue Market Share by Application (2024-2034)
Table 31. North America mRNA Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 32. North America mRNA Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America mRNA Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 34. Europe mRNA Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. Europe mRNA Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe mRNA Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 37. Asia-Pacific mRNA Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 38. Asia-Pacific mRNA Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific mRNA Treatment Market Size by Region (2024-2034) & (US$ Million)
Table 40. Latin America mRNA Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Latin America mRNA Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America mRNA Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 43. Middle East & Africa mRNA Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Middle East & Africa mRNA Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa mRNA Treatment Market Size by Country (2024-2034) & (US$ Million)
Table 46. CureVac Company Detail
Table 47. CureVac Business Overview
Table 48. CureVac mRNA Treatment Product
Table 49. CureVac Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 50. CureVac Recent Development
Table 51. Moderna Company Detail
Table 52. Moderna Business Overview
Table 53. Moderna mRNA Treatment Product
Table 54. Moderna Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 55. Moderna Recent Development
Table 56. BioNTech (Pfizer) Company Detail
Table 57. BioNTech (Pfizer) Business Overview
Table 58. BioNTech (Pfizer) mRNA Treatment Product
Table 59. BioNTech (Pfizer) Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 60. BioNTech (Pfizer) Recent Development
Table 61. Sanofi (Translate Bio) Company Detail
Table 62. Sanofi (Translate Bio) Business Overview
Table 63. Sanofi (Translate Bio) mRNA Treatment Product
Table 64. Sanofi (Translate Bio) Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 65. Sanofi (Translate Bio) Recent Development
Table 66. Ethris (AstraZeneca) Company Detail
Table 67. Ethris (AstraZeneca) Business Overview
Table 68. Ethris (AstraZeneca) mRNA Treatment Product
Table 69. Ethris (AstraZeneca) Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 70. Ethris (AstraZeneca) Recent Development
Table 71. Kernal Biologics Company Detail
Table 72. Kernal Biologics Business Overview
Table 73. Kernal Biologics mRNA Treatment Product
Table 74. Kernal Biologics Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 75. Kernal Biologics Recent Development
Table 76. RaNA Therapeutics Company Detail
Table 77. RaNA Therapeutics Business Overview
Table 78. RaNA Therapeutics mRNA Treatment Product
Table 79. RaNA Therapeutics Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 80. RaNA Therapeutics Recent Development
Table 81. Silence Therapeutics Company Detail
Table 82. Silence Therapeutics Business Overview
Table 83. Silence Therapeutics mRNA Treatment Product
Table 84. Silence Therapeutics Revenue in mRNA Treatment Business (2018-2023) & (US$ Million)
Table 85. Silence Therapeutics Recent Development
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Global mRNA Treatment Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global mRNA Treatment Market Share by Type: 2024 VS 2034
Figure 3. Vaccine Features
Figure 4. Drugs Features
Figure 5. Global mRNA Treatment Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global mRNA Treatment Market Share by Application: 2024 VS 2034
Figure 7. Protein Diseases Case Studies
Figure 8. Gene Dysfunction Diseases Case Studies
Figure 9. Others Case Studies
Figure 10. mRNA Treatment Report Years Considered
Figure 11. Global mRNA Treatment Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 12. Global mRNA Treatment Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global mRNA Treatment Market Share by Region: 2024 VS 2034
Figure 14. Global mRNA Treatment Market Share by Players in 2024
Figure 15. Global Top mRNA Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Treatment as of 2024)
Figure 16. The Top 10 and 5 Players Market Share by mRNA Treatment Revenue in 2024
Figure 17. North America mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 18. North America mRNA Treatment Market Share by Country (2018-2034)
Figure 19. United States mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. Canada mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Europe mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe mRNA Treatment Market Share by Country (2018-2034)
Figure 23. Germany mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. France mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. U.K. mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. Italy mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Russia mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Nordic Countries mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Asia-Pacific mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific mRNA Treatment Market Share by Region (2018-2034)
Figure 31. China mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Japan mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. South Korea mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Southeast Asia mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. India mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Australia mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Latin America mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America mRNA Treatment Market Share by Country (2018-2034)
Figure 39. Mexico mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Brazil mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Middle East & Africa mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa mRNA Treatment Market Share by Country (2018-2034)
Figure 43. Turkey mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Saudi Arabia mRNA Treatment Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. CureVac Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 46. Moderna Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 47. BioNTech (Pfizer) Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 48. Sanofi (Translate Bio) Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 49. Ethris (AstraZeneca) Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 50. Kernal Biologics Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 51. RaNA Therapeutics Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 52. Silence Therapeutics Revenue Growth Rate in mRNA Treatment Business (2018-2023)
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed